Abstract
The increasing prevalence of antimicrobial resistance (AMR) and biofilm-associated infections represents a major challenge in both biomedical and environmental settings. Herein, we report the synthesis and comprehensive evaluation of a multifunctional nanocomposite composed of baicalein-coated Fe3O4/Ag nanoparticles (FAB NPs), designed to combine magnetic recoverability, controlled silver (Ag+) release, antimicrobial activity, and improved biocompatibility. FAB NPs were synthesized via a stepwise coprecipitation approach and characterized in terms of morphology, structure, surface chemistry, magnetic properties (normalized saturation magnetization of 27.2 ± 0.1 emu/g), antioxidant capacity (43.8% 2,2-diphenyl-1-picrylhydrazyl inhibition at 1.5 mg/mL), and antibacterial potential (minimum inhibitory concentrations of 0.19–0.38 mg/mL), as well as Ag+ release behavior. The developed nanocomposite exhibited strong broad-spectrum antibacterial activity against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, together with pronounced inhibition of biofilm formation (>60%) and quorum sensing (QS), while achieving a 33-fold reduction in Ag+ release compared to nonfunctionalized Fe3O4/Ag nanoparticles. Mechanistic studies revealed that FAB NPs disrupt bacterial membranes and interfere with QS pathways (suppressing 25% of violacein expression), contributing to their antibiofilm efficacy. Importantly, FAB NPs displayed improved biocompatibility toward human keratinocytes and fibroblasts and did not promote significant resistance development during 55 days of exposure in both Gram-positive and Gram-negative bacteria. As a proof of concept for environmental applications, FAB NPs incorporated into activated carbon packed-bed columns achieved complete removal of the reference faecal indicator E. coli from contaminated water, with negligible Ag+ leaching. Overall, this work demonstrates that baicalein functionalization enables the design of safe and highly effective Ag-based magnetic nanocomposites, offering a versatile strategy to combat microbial contamination and AMR in both biomedical and water treatment applications.
Keywords: antibiotic resistance, magnetic nanoparticles, antibacterial, antibiofilm, quorum sensing, water treatment


1. Introduction
The alarming rise in antimicrobial resistance (AMR), together with the challenges posed by microbial biofilm formation, presents significant concerns in both biomedical and environmental settings. Biofilms not only protect bacterial communities from conventional therapies and disinfection methods but also promote the horizontal transfer of resistance genes, thereby fuelling the spread of multidrug-resistant strains. − While these phenomena are most commonly associated with clinical infections, they also pose serious limitations in environmental contexts such as water treatment systems and industrial processes, where biofilms contribute to persistent contamination and the dissemination of resistant microorganisms. −
Nanotechnology offers promising strategies to combat AMR and microbial biofilm establishment and proliferation, particularly using metal-containing nanoparticles (NPs). Among these, silver NPs (Ag NPs) have been extensively investigated due to their potent broad-spectrum antimicrobial activity and their ability to disrupt biofilm structures. Through reduction with an appropriate agent, silver ions (Ag+) can be converted into nanoscale particles with applications across diverse sectors, including medicine, textiles, food packaging, and water treatment, among others. However, the practical uses of Ag NPs remain limited by challenges such as aggregation, cytotoxicity, and uncontrolled silver (Ag+) release. Hybrid nanomaterials have therefore emerged as a promising strategy to improve NPs stability, control ion release, and enhance overall biological performance.
Magnetite NPs (Fe3O4 NPs), another widely used class of metal-containing nanomaterials, have also shown promise in a wide range of applications, including biomedicine and wastewater treatment. In environmental applications, they are particularly attractive as efficient adsorbents due to their magnetic recoverability. When functionalized or integrated into hybrid nanostructures, Fe3O4-based nanocomposites can contribute to water disinfection, offering safer and more sustainable treatment processes. This strategy facilitates the postuse recovery of metal-containing NPs, thereby mitigating safety concerns associated with their nonbiodegradability and potential bioaccumulation. In addition, magnetic supports can stabilize metal-based NPs, limit their dispersion, and enable efficient reuse, potentially reducing operational costs. Beyond their role in environmental remediation, Fe3O4 based systems are also widely explored in biomedicine, where stringent criteria related to biocompatibility, inflammatory response, stable metal immobilization, and targeted delivery to specific cells or tissues become critical. −
Unlike conventional antibiotics, which typically act through a single mechanism, , metal-based nanoparticles exert antimicrobial activity through multiple pathways, including membrane disruption, oxidative stress induction, and quorum sensing inhibition, ,,, thereby reducing the likelihood of resistance development. In parallel, surface functionalization with naturally occurring biomolecules such as baicalein, a flavonoid with antimicrobial, antioxidant, and anti-inflammatory properties, represents an effective strategy to enhance nanoparticle stability, biocompatibility, and therapeutic efficacy while generating synergistic antimicrobial effects. ,−
In this study, we report the synthesis and characterization of a novel baicalein-coated Fe3O4/Ag NPs (FAB NPs). By integrating the biocidal activity of Ag+, the magnetic responsiveness of Fe3O4, and the bioactivity of baicalein, we developed a multifunctional nanomaterial with antioxidant, antimicrobial, and biofilm-disrupting properties. FAB also combines magnetic responsiveness, controlled Ag+ release, improved biocompatibility, and reduced resistance development against three clinically and environmentally relevant pathogens. Moreover, the applicability of FAB NPs as a filler material for water disinfection was evaluated in packed-bed column systems as a proof of concept. Overall, this work highlights the potential of FAB NPs as a versatile strategy to combat microbial spread and colonisation in both environmental and biomedical contexts.
2. Materials and Methods
2.1. Reagents and Cells
Iron(II) chloride (FeCl2), iron(III) chloride hexahydrate (FeCl3·6H2O), silver nitrate (AgNO3), sodium hydroxide (NaOH), baicalein, dimethyl sulfoxide (DMSO), coliform ChromoSelect agar, cetrimide agar, Baird–Parker agar, and Luria–Bertani (LB) medium were purchased from Sigma-Aldrich (Spain). Mueller Hinton broth (MHB) and tryptic soy broth (TSB) were provided by Sharlab (Spain). Phosphate-buffered saline solution (PBS; 100 mM pH 7.4) was obtained from Fisher BioReagents (USA). Phosphatidylethanolamine (PE, No. 840027) and phosphatidylglycerol (PG, No. 841188) extracted from E. coli were provided by Avanti Research Inc. (USA). Bacterial strains Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC 10145), human fibroblast cells (ATCC-CRL-4001, BJ-5ta), and human keratinocyte cells (HaCaT cell line) were obtained from the American Type Culture Collection (ATCC LGC Standards, Spain). Chromobacterium violaceum (CECT 5999) was purchased from the Spanish Type Culture Collection (CECT, Spain).
2.2. Synthesis of Nanoparticles
Fe3O4, Fe3O4/Ag, and baicalein-coated Fe3O4/Ag NPs (hereafter defined as Fe3O4 NPs, FA NPs, and FAB NPs, respectively) were synthesized using the coprecipitation method, with NaOH acting as a precipitating agent (Figure S1). Synthesis of Fe3O4 NPs: a solution of Fe2+/Fe3+ in a molar ratio of 1:2 was prepared by dissolving 50.0 mg of FeCl2 and 213.2 mg of FeCl3·6H2O in 50 mL ultrapure (Milli-Q) water and stirred at 60 °C for 1 h. The pH of the solution was then adjusted to 12 by adding 1 M NaOH under continuous stirring (200 rpm). An immediate color change to black was observed, and the reaction mixture was stirred for an additional hour at 60 °C. The resulting particles were magnetically separated and washed three times with Milli-Q water. Finally, the material was freeze-dried for 24 h using a Telstar LyoAlfa 15 lyophilizer (Italy) and stored at room temperature until further use.
Synthesis of FA NPs: Fe3O4 NPs were first synthesized as described above. Next, 40 mg of AgNO3 was added to the suspension and the mixture was stirred for 30 min at 60 °C. The FA NPs were then washed, lyophilized, and stored as previously described.
Synthesis of FAB NPs: following the synthesis of FA NPs, 25 mg of baicalein (dissolved in 1 mL of DMSO) was added to the NPs suspension and stirred for another 30 min at 60 °C. The resulting particles were magnetically separated and washed three times with Milli-Q water. Finally, FAB were lyophilized and stored until further use as described above.
2.3. Characterization of Nanoparticles
The ζ-potential, hydrodynamic size, and polydispersity index (PDI) were measured with a Zetasizer Nano Z (Malvern Instruments Ltd., UK). Prior to analysis, the NPs were dispersed by sonication for 15 min using a Sonopuls HD 2070 ultrasonic homogenizer (Bandelin Electronic GmbH & Co., Germany) with a 3 mm probe. The instrument was operated at 50% amplitude in a pulse mode (0.2 s on/0.8 s off), while the suspension was kept in an ice bath to prevent overheating. X-ray diffraction (XRD) spectra were obtained in a Bruker D8 Advance diffractometer (Bruker Inc., USA). The morphology and the size of the NPs were analyzed using transmission electron microscopy (TEM), high-resolution TEM (HRTEM), scanning TEM (STEM), energy dispersive X-ray (EDX), and selected area electron diffraction (SAED) by casting 10 μL of sample onto a copper grid, air-dried for 15 min, and imaged in a JEOL JEM-2011 high-resolution transmission electron microscope operated at 200 kV (JEOL Ltd., Japan). The NPs were further characterized by X-ray photoelectron spectroscopy (XPS) using a SPECS system equipped with a PHOIBOS 150 MCD-9 XP hemispherical analyzer and a high-intensity XR50 twin-anode X-ray source (Mg Kα, 1253 eV; Al Kα, 1487 eV) operated at 150 W (SPECS Surface Nano Analysis GmbH, Germany). Magnetic properties were measured with a Vibrating Sample Magnetometer (VSM; MicroSense LLC., model ADE–EV9, USA).
Phenolic content was assessed using the Folin–Ciocâlteu spectrophotometric method. Suspensions of Fe3O4, FA, and FAB NPs were prepared in Milli-Q water (1 mg/mL), after which 20 μL of each sample was mixed with 80 μL of 0.2 N Folin-Ciocâlteu reagent and 100 μL of 20% (w/v) Na2CO3, and incubated for 10 min in darkness. The absorbance was measured at 765 nm, and the total phenolic content was calculated using a calibration curve prepared with gallic acid as standard.
The antioxidant activity of the Fe3O4, FA, and FAB NPs was assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. Briefly, 100 μL of NPs suspension was mixed with 300 μL of 60 μM DPPH in methanol and incubated in the dark at room temperature for 30 min. Water and ascorbic acid (1 mg/mL) were used as negative and positive controls, respectively. Absorbance at 517 nm was measured to determine radical scavenging activity.
The content of Ag+ in FA and FAB was evaluated by inductively coupled plasma mass spectrometry (ICP-MS; Model 7800, Agilent). Briefly, 25 ± 0.5 mg of NPs were submerged in 1 mL of PBS and incubated at 37 °C and 230 rpm for 7 days. Every 24 h, the suspensions were sampled after magnetic separation using a neodymium magnet at room temperature, and the withdrawn volume was replenished with fresh PBS. Then, each sample was digested in a solution of 20% (v/v) nitric acid at 70 °C for 24 h. The digested samples were diluted with Milli-Q water to adjust the acid concentration of each sample to 2% (v/v) nitric acid. Finally, each sample was filtered using a 0.22 μm Millipore Express PES Membrane filter before quantifying the concentration of Ag+ with ICP-MS.
2.4. Antibacterial Activity of Nanoparticles
Fe3O4, FA and FAB NPs were tested against S. aureus (Gram-positive), P. aeruginosa (Gram-negative) and E. coli (Gram-negative) via colony-counting on nutritive agar plates. Bacterial cultures were grown overnight in Mueller-Hinton broth (MHB) at 37 °C with shaking (230 rpm) and subsequently diluted in fresh MHB to an optical density at 600 nm (OD600) of approximately 0.01, corresponding to 105–106 colony-forming units per milliliter (CFU/mL). NP dilutions (starting at 3.0 mg/mL) were prepared by 2-fold serial dilution in MHB in 96-well polypropylene microplates. Each well was then inoculated with an equal volume of bacterial suspension (1:1, v/v) and incubated for 24 h at 37 °C with shaking (230 rpm). Bacterial growth was quantified by measuring the OD600 before and after 24 h of incubation, and cell viability at each dilution was confirmed by plating 10 μL aliquots onto nutritive agar plates, followed by static incubation at 37 °C overnight. Results were expressed as the percentage of growth inhibition. Furthermore, the formation of a protein corona on FAB NPs was evaluated by incubating 800 μL of NP suspension (5 mg/mL) with 200 μL of fetal bovine serum at 37 °C and 230 rpm for 10 min. The samples were centrifuged at 18,000 g for 10 min at 4 °C to pellet the NPs together with the adsorbed proteins, while unbound serum proteins remained in the supernatant. The protein-corona-coated NPs were resuspended in fresh medium and assessed for antibacterial activity as described above.
2.5. Biofilm Inhibition
The ability of Fe3O4, FA, and FAB NPs to inhibit biofilm formation by S. aureus, P. aeruginosa, and E. coli was evaluated as described following a previously reported procedure. Briefly, overnight bacterial cultures in TSB were diluted to an OD600 of 0.01. Then, 50 μL of NPs at different concentrations (starting at 3 mg/mL) were mixed with 50 μL of bacterial suspension in 96-well microplates and incubated for 24 h under static conditions at 37 °C. After incubation, wells were washed with distilled water, and biofilms were fixed at 60 °C. Fixed biofilms were stained with 0.1% (w/v) crystal violet for 10 min, washed, and dried at 60 °C. The bound dye was solubilized with 200 μL of 30% (v/v) acetic acid, and the absorbance of 125 μL from each well was measured at 595 nm to quantify biofilm formation.
2.6. Quorum Sensing (QS) Inhibition
2.6.1. QS Inhibition in Gram-Positive Bacteria
Two methicillin-resistant S. aureus strains were used: USA300agr IR P2-GFP, in which GFP is expressed under the agr P2 promoter (reporting QS signaling), and USA300agr IR P3-GFP, in which GFP is expressed under the agr P3 promoter (reporting activation of the RNAIII regulon). These reporter strains allow quantification of changes in agr signaling, which is normally triggered by autoinducing peptides and controls transcription of RNAIII, the main effector of agr-regulated virulence gene expression in S. aureus. Overnight cultures were grown in TSB supplemented with 4.5 μg/mL chloramphenicol (TSB-C) at 37 °C with shaking (230 rpm), diluted to OD600 ≈ 0.01 in TSB-C, and mixed with equal volumes (50 μL) of Fe3O4, FA, or FAB NPs (0.38 mg/mL) in 96-well microplates. After 24 h incubation at 37 °C with shaking, OD600 and GFP fluorescence (λex = 485 nm, λem = 535 nm) were measured using a microplate reader (Infinite M200, TECAN, Austria). Controls included bacteria without NPs, NPs in TSB-C without bacteria, and media alone. GFP fluorescence was first normalized to OD600 to account for cell density, and then expressed relative to the fluorescence value measured for the untreated bacterial control.
2.6.2. QS Inhibition in Gram-Negative Bacteria
C. violaceum (CECT 5999), a violacein-producing strain dependent on acyl-homoserine lactone (AHL), was used as reporter strain. In this strain, violacein production is regulated by an AHL-dependent LuxI/LuxR-type QS circuit (CviI/CviR), allowing assessment of interference with AHL-mediated signaling. Overnight cultures were grown in LB supplemented with kanamycin (25 μM), adjusted to OD600 ≈ 0.4, supplemented with AHL (333 μM) to induce QS, and mixed in a ratio 1:1 with Fe3O4, FA, or FAB NPs (0.38 mg/mL). After 2 h of incubation at 30 °C with shaking (230 rpm), cultures were diluted with fresh LB containing kanamycin and AHL (166 μM) to maintain QS activation and, and the resulting 3 mL cultures were incubated overnight under the same conditions. Negative and positive controls were prepared with or without NPs and AHL. Bacterial growth was assessed by measuring OD600, while bacterial viability was assessed by colony-forming unit (CFU) counting after preparing 10-fold serial dilutions in PBS (10–1 – 10–8) and plating on LB-kanamycin (25 μM) agar. For violacein quantification, each culture was centrifuged (20,000 g, 4 °C, 5 min); the resulting pellet was resuspended in 1 mL of ethanol, and the cells were lysed using ultrasound (Bandelin Sonopuls HD 2070) operating at 50% amplitude. After removal of cell debris by centrifugation, violacein content in the supernatant was quantified by measuring absorbance at 595 nm using an Infinite M200 microplate reader (TECAN, Austria). Violacein production was expressed as a percentage relative to the positive control (AHL-induced bacteria without NPs), following normalization to bacterial biomass.
2.7. SEM Analysis of Bacterial Morphology
The effect of FAB NPs on bacterial cell microstructure was examined by SEM. Overnight cultures of S. aureus, P. aeruginosa, and E. coli were grown in MHB at 37 °C, centrifuged, and washed twice with PBS. The cells were then resuspended in PBS to an OD600 of ∼ 0.5 and exposed to 0.38 mg/mL FAB NPs. The mixture was incubated for 4 h at 37 °C with shaking (230 rpm). After incubation, 3 mL of each sample were filtered through a sterile cellulose membrane (0.22 μm pore size). The retained bacterial cells were fixed using a solution of paraformaldehyde (2% v/v) and glutaraldehyde (2.5% v/v) in PBS. SEM images were acquired using a Zeiss Merlin field-emission scanning electron microscope (Jena, Germany) operated at 3 kV by the Microscopy and X-ray Diffraction Service (SMiDRX) of the Universitat Autonoma de Barcelona.
2.8. Membrane Interaction
The interaction of FAB NPs with bacterial membranes was investigated using Langmuir monolayers. A phospholipid mixture of PE and PG in an 8:2 molar ratio was used to mimic a Gram-negative bacterial membrane. Monolayers were formed in a KSV NIMA Langmuir–Blodgett trough (model KN2002) equipped with symmetric mobile barriers and a Wilhelmy plate for surface pressure measurement. The trough was mounted on an antivibration table and enclosed in an insulated chamber maintained at 21 ± 1 °C. Prior to each experiment, the trough and barriers were cleaned with chloroform and rinsed with Milli-Q water. Then, 30 μL of a 0.5 g/L phospholipid solution in chloroform was spread onto the PBS subphase in the absence or presence of FAB NPs. A control containing PBS and NPs without phospholipids was also included. After 15 min of solvent evaporation, the monolayers were compressed and π-A isotherms were recorded.
2.9. Cytotoxicity Against Mammalian Cells
The cytotoxicity of Fe3O4, FA, and FAB NPs was evaluated using human keratinocyte and fibroblasts cell lines. Following seeding, cells were exposed to the NPs (from 0.05 to 1.5 mg/mL) and incubated for 24 h. Cell viability was then assessed using the Alamar Blue assay, as previously described. Cell morphology and viability were further evaluated using the LIVE/DEAD Viability/Cytotoxicity Kit (Invitrogen, USA). Briefly, cells were incubated with calcein-AM and ethidium homodimer-1 according to the manufacturer’s instructions, washed with PBS to remove excess dye, and observed under a fluorescence microscope (NIKON Eclipse Ti–S, Japan).
2.10. Resistance Development Assay
The potential for resistance development of FAB NPs was evaluated against S. aureus and E. coli following standard procedures, using 2-fold serial dilutions in nutrient medium and visual inspection of bacterial growth after 24 h of incubation at 37 °C to determine the minimum inhibitory concentration (MIC). On Day 1, the MIC of FAB NPs was determined for both bacterial strains, whereas the MIC of ciprofloxacin was tested only for S. aureus and the MIC of ampicillin only for E. coli. From Day 2 onward, samples showing bacterial growth at the highest NPs or antibiotic concentration were used as the inoculum for the next day. The inoculum was diluted 1:50 in fresh MHB before performing the MIC assay for the subsequent day. This procedure was repeated for 55 consecutive days, and changes in the MIC relative to Day 1 were recorded daily to monitor the development of resistance.
2.11. Evaluation of FAB NPs in Packed Bed Columns for Water Disinfection
Prior to water filtration, FAB NPs were immobilized by magnetic retention using a magnetic layer comprising 61 neodymium magnets (3 mm diameter, N42 grade, chromium-plated magnetic spheres). The magnetic layer was loaded with 70 mg of FAB NPs by incubation in a NPs suspension prepared in ultrapure water, after which the coated layers were freeze-dried prior to use.
Water filtration experiments were carried out using 60 mL syringes without plungers as columns, packed with 12 g of activated carbon (AC; specific surface area 850 m2/g; MGR 800, Chiemivall, Spain), confined between two stainless-steel filters (120 mesh). Two magnetic layers were placed within the AC bed: a FAB NP-coated magnetic layer (∼6.6 g) positioned 1.5 g below the top of the bed and an uncoated magnetic layer (∼6.6 g) positioned 1.5 g above the bottom of the column (Figure S2). The bottom magnetic layer was included to capture and retain any NPs potentially released from the upper coated layer. In addition, a control filtration column containing only uncoated magnetic layers was used to confirm that bacterial removal was attributable to the presence of the NPs.
Filtration experiments were performed following a procedure using an adapted procedure based on previously reported methodology. A 100 mL of E. coli suspension (ATCC 25922; ∼ 107 CFU/mL) was recirculated through the columns using a peristaltic pump at a flow rate of 8.6 mL/min. The bacterial suspension was continuously stirred at 230 rpm to prevent cell sedimentation. The efficiency of E. coli removal was evaluated by colony counting after 30 min, 1, 2, 4, and 18 h of filtration.
2.12. Statistical Analysis
All experiments were conducted in triplicate (n = 3) and results are presented as the mean values ± standard deviation (S.D.). Statistical analyses were performed using OriginPro 8.5 software (OriginLab, USA). One-way analysis of variance (ANOVA) followed by Tukey’s posthoc test was used to assess significant differences between groups, with a confidence level of 95% (p < 0.05).
3. Results and Discussion
3.1. Nanoparticles Characterization
Fe3O4, FA and FAB NPs were prepared through a stepwise synthesis. First, Fe3O4 NPs were obtained by coprecipitation using NaOH, followed by sequential Ag0 deposition from AgNO3, and subsequent baicalein functionalization. The initial ζ-potential of Fe3O4 NPs was – 29.6 ± 1.6 mV, which increased to +4.9 ± 1.3 mV upon the addition of AgNO3, indicating a significant surface modification due to Ag+ reduction and deposition leading to the formation of a heterostructured Fe3O4/Ag nanocomposite (FA). After the introduction of baicalein, the ζ-potential shifted to – 18.5 ± 1.9 mV, suggesting further surface functionalization and moderate colloidal stability of the resulting FAB NPs (Figure S3). TEM imaging revealed that all three types of NPs were predominantly spherical (Figure A, Figure S4A, Figure S5A) with average diameters ranging from 8 to 12 nm (Figure B, Figure S4B, Figure S5B). Aggregates were observed in all samples, likely due to magnetic interactions, though FAB NPs formed smaller aggregates (Figure A), possibly reflecting reduced magnetic interactions after Ag and baicalein incorporation. It is noteworthy that hydrodynamic size and polydispersity index are not reported here, as dynamic light scattering measurements are unreliable for strongly magnetic NPs.
1.
(A) TEM image, (B) size distribution data, (C) EDX spectrum, and (D) XPS spectra of FAB NPs.
EDX analysis demonstrated the presence of Fe, O, and Ag elements, confirming the incorporation of the metal on FAB (Figure C) and FA NPs (Figure S4C), while Fe3O4 NPs contained only Fe and O (Figure S5C). These results are consistent with the Ag 3d doublets at 367.2 – 367.8 eV (3d5/2) and 373.3 – 374.0 eV (3d3/2) in the XPS spectra, confirming the presence of metallic silver (Ag0) on the surface of both FAB (Figure D) and FA NPs (Figure S4D). In addition, the Fe 2p XPS spectrum of FAB (Figure D) exhibited peaks at ∼ 711–712 eV, reflecting an increased Fe3+/Fe2+ ratio, consistent with partial oxidation of Fe2+ associated with the reduction of Ag+ to Ag0. Similarly, FA NPs show similar Fe 2p features than FAB NPs (Figure S4D), while Fe3O4 NPs display the characteristic mixed Fe2+/Fe3+ contributions of magnetite (Figure S5D). XPS analysis of FAB NPs (Figure D) also revealed complex O 1s and C 1s envelopes, displaying a high-intensity O 1s peak around 531 eV (attributed to C–OOH groups), and a combination of nonoxygenated carbon (C–C at 284.4 eV) and oxygenated carbon species (C–O at 286 eV and CO at 287.7 eV), confirming the presence of organic functionalities on the NPs surface derived from baicalein. In contrast, FA NPs showed a high-intensity O 1s peak at 530.2 eV, associated with Fe–O or Ag–O (Figure S4D), while Fe3O4 NPs displayed a high-intensity O 1s peak at 529.3 eV (Figure S4D) corresponding to the O-lattice of magnetite bonded to Fe2+/Fe3+. ,
The successful incorporation of Ag0 and baicalein on FAB NPs, as confirmed by EDX and XPS, had a direct impact on their magnetic properties. As all three NPs (Fe3O4, FA, and FAB) are composed of magnetite, their magnetic behavior was first visually assessed using a neodymium magnet (for illustration purposes only), with all samples responding positively (Figure A). Quantitative evaluation was performed by VSM, with hysteresis loops showing sigmoidal magnetization curves, negligible coercivity (Hc ∼ 0) and remanence (M r ∼ 0), characteristic for superparamagnetic behavior and full saturation at high fields. The normalized saturation magnetization (Ms) decreased in the order Fe3O4 NPs (37.6 ± 0.1 emu/g) > FA NPs (33.5 ± 0.1 emu/g) > FAB NPs (27.2 ± 0.1 emu/g). The drop in Ms for FA compared to Fe3O4 NPs is attributed to the presence of nonmagnetic Ag0, while the further decrease in FAB NPs is consistent with the addition of the organic, nonmagnetic baicalein (Figure B), with possible contributions from surface spin disorder and reduced crystallinity induced by Ag0 and baicalein.
2.
(A) Photographs of the NPs under a magnetic field. (B) VSM hysteresis loops showing the stepwise reduction in saturation magnetization for Fe3O4, FA and FAB NPs.
This decrease in Ms was further supported by structural characterization of the NPs. XRD spectrum of FAB NPs (Figure A) displays sharp peaks at 2θ values of 29.88°, 35.23°, 43.69°, 57.02°, 62.63°, corresponding to the (220), (311), (400), (511), and (440) planes, respectively. These peaks agree with the Fe3O4 NPs XRD pattern (Figure S6A) and are consistent with a face-centered cubic (FCC) structure. Additional peaks at 37.91° (111), 46.11° (200), 64.21° (220), and 77.12° (311) are present in FAB NPs, corresponding to FCC of Ag0, and are also observed in the XRD pattern of FA NPs (Figure S7A), confirming successful silver deposition. Notably, the peak at 53.14°, assigned to the (422) plane in Fe3O4 and FA NPs, is no longer evident in FAB NPs, potentially due to the presence of baicalein, which can reduce crystallinity, a factor known to contribute to decreased Ms in magnetic NPs. XRD parameters are summarized in Table S1. SAED analysis corroborated these findings, with FAB NPs exhibiting three diffraction rings corresponding to the 220, 311, and 111 planes (Figure B), whereas Fe3O4 NPs displayed six rings (220–511 planes) and FA NPs five rings in the same range (Figure S6B and Figure S7B). HRTEM imaging of FAB NPs revealed lattice fringes corresponding to 220, 311, 400, and 422 atomic planes (Figure C), confirming the crystal structure identified by XRD and SAED. Similar lattice fringe analysis was performed for Fe3O4 and FA NPs (Figure S6C and Figure S7C). Taken together, XRD, SAED, and HRTEM analyses indicate that the magnetite core structure remains practically intact, with minor loss of long-range crystallographic order. Therefore, these results support the conclusion that the observed decrease in Ms (Figure B) is not due to disruption of the crystal lattice, but rather to the incorporation of nonmagnetic Ag0 and baicalein layers, and potential surface spin disorder.
3.
(A) XRD pattern, (B) SAED pattern, and (C) HRTEM images with lattice fringes of FAB NPs.
Fe3O4 and FA NPs showed no measurable phenolic content, indicating that neither the magnetite core nor the Ag0 coating contributes phenolic functionalities. In contrast, FAB NPs exhibited a significant increase in phenolic content from 0 to 0.77 μmol GAE/mg following baicalein functionalization, confirming the successful incorporation of the polyphenolic compound on the NPs surface (Figure A). The antioxidant activity of the three NPs across various concentrations revealed that Fe3O4 and FA NPs did not display radical-scavenging activity, indicating that neither the core nor the Ag0 shell contributes to DPPH inhibition, as expected. By contrast, FAB NPs exhibited dose-dependent antioxidant activity, with the highest inhibition observed at 1.5 mg/mL (∼43.8%) and decreasing to ∼ 0.83% at 0.05 mg/mL, highlighting the functional role of baicalein in imparting antioxidant properties (Figure B).
4.
(A) Phenolic content and (B) antioxidant activity of Fe3O4, FA, and FAB NPs (C: ascorbic acid = 1 mg/mL).
3.2. Antibacterial Activity
The antimicrobial activity of the Fe3O4, FA and FAB NPs across various concentrations was tested against three relevant pathogens, with E. coli and P. aeruginosa representing ubiquitous environmental and opportunistic bacteria, and S. aureus providing additional relevance for biomedical and wastewater-associated contexts. Consistent with earlier reports, Fe3O4 NPs, demonstrated intrinsic antibacterial activity. However, the combination of Fe3O4 NPs with additional bioactive agents has been shown to further enhance their antimicrobial efficacy. , In this study, FAB NPs exhibited significantly improved antibacterial profiles, achieving complete inhibition at 0.19 mg/mL for S. aureus and P. aeruginosa, and at 0.38 mg/mL for E. coli. These values were essentially identical to those obtained with FA NPs and lower than those of Fe3O4 NPs, which showed only partial inhibition even at 1.5 mg/mL (Figure ). Therefore, baicalein functionalization did not reduce the antimicrobial performance of FA NPs, and both FA and FAB NPs can be considered broadly comparable in terms of antimicrobial efficacy. Importantly, FAB NPs preincubated in serum to allow protein-corona formation exhibited complete inhibition of all three evaluated strains at the same concentrations as untreated NPs, indicating that nonspecific protein adsorption does not compromise their antibacterial activity under protein-rich conditions. However, the flavonoid incorporation reduced the release rate of Ag+ and limited the cumulative release to 0.011 ± 0.002% (equivalent to 0.52 ± 0.11 mg/L) of the total silver content of FAB NPs after 7 days (168 h), indicating that baicalein effectively modulates and stabilizes silver availability (Figure ). A plausible explanation, consistent with the known chemistry of flavonoids, is that the phenolic groups of baicalein interact with surface Ag0 through weak coordination or hydrogen-bonding interactions, and that its antioxidant character may reduce the extent of Ag0 oxidation. Both effects would contribute to a slower conversion of Ag0 into Ag+ and thus to the reduced release observed experimentally. Electrostatic or surface-stabilizing interactions between baicalein and the Ag domains may also play a role, although this cannot be conclusively established with the current data set. Importantly, the release profiles show a markedly lower cumulative Ag+ release in baicalein-functionalized samples, supporting the interpretation that baicalein modulates Ag0 surface reactivity rather than acting as a simple physical diffusion barrier. These results are consistent with previous reports describing surface functionalization with naturally occurring biomolecules as an effective strategy to improve the stability of metal-containing NPs. ,− In contrast, FA NPs exhibited a sustained and progressive metal release, characterized by a gradual decline in release rate over time and the absence of a plateau within the experimental window, reaching a maximum cumulative Ag+ release of 0.362 ± 0.023% (equivalent to 1.53 ± 0.10 mg/L) of the total NPs silver content over the same period.
5.

Bacterial cell viability (%) of S. aureus (A), P. aeruginosa (B), and E. coli (C) after exposure to different concentrations of Fe3O4, FA, and FAB NPs. “C” on the x-axis denotes the control group bacteria without NPs.
6.

Cumulative Ag+ release profiles of FA and FAB NPs over 7 days (168 h).
Given that FAB and FA NPs display comparable antimicrobial activity across the three bacterial strains (Figure ), despite the substantially lower Ag+ release of FAB NPs, these results suggest that baicalein contributes to the antibacterial effect, either directly or by facilitating Ag+ action, for example through membrane related effects. In line with this interpretation, baicalein has been reported to disrupt the inner and outer membranes of Gram-negative bacteria showing a synergistic effect with multiple antibiotics. More recently, the broad-spectrum antimicrobial activity of baicalein and its potential as an antibiotic adjuvant have been highlighted, further supporting the view that the flavonoid can enhance the antibacterial efficacy through complementary mechanisms. Overall, FAB NPs maintain the antimicrobial performance of FA NPs while reducing metal exposure, a combination that may translate into lower cytotoxicity and broader applicability in biomedical and environmental contexts.
3.3. Biofilm Inhibition Activity
Biofilms enhance pathogen persistence in clinical and environmental settings by increasing AMR, shielding cells from immune clearance, and facilitating horizontal gene transfer. − FA and FAB NPs significantly inhibited biofilm establishment, whereas Fe3O4 NPs exhibited a weaker effect (Figure ). Biofilm-forming capacity was significantly reduced (>60%) at concentrations of 0.75 mg/mL for S. aureus and 0.19 mg/mL for P. aeruginosa and E. coli following treatment with FA and FAB NPs. In contrast, Fe3O4 NPs required concentrations as high as 1.5 mg/mL to achieve biofilm inhibition of approximately 40 – 50% across all three tested pathogens. These results are consistent with those shown in Figure , as the antibacterial activity observed for all three NPs types is expected to have a corresponding impact on bacterial biofilm formation.
7.

Biofilm formation of S. aureus (A), P. aeruginosa (B), and E. coli (C) after contacting them with FA, FAB, and Fe3O4 NPs. “C” on the x-axis denotes the control group.
Quorum sensing (QS) plays a fundamental role in the regulation of bacterial virulence and biofilm formation. In this context, the QS inhibition activity of Fe3O4, FA, and FAB NPs revealed clear distinctions between Gram-negative and Gram-positive systems (Figure ). In C. violaceum, normalized violacein quantification confirmed that Fe3O4 NPs had no measurable effect on QS-regulated pigment production, whereas FA NPs suppressed violacein expression by approximately 25%. Under the same conditions, FAB NPs induced a more pronounced decline in violacein per viable cell, demonstrating a greater effect to QS disruption (Figure A). This effect could be attributed, at least in part, to the release of Ag+ ions from FA NPs (Figure ). Silver-based NPs (e.g., polyvinylpyrrolidone- and citrate-coated Ag NPs) have been reported to disrupt QS by interfering with the biosynthesis and accumulation of AHL signal molecules, thereby attenuating violacein production in C. violaceum. −
8.
Inhibition of QS in (A) Gram-negative C. violaceum and (B) Gram-positive S. aureus (strains P2 and P3) following exposure to Fe3O4, FA, and FAB NPs. “C” on the x-axis indicates control groups.
In addition, baicalein has been described as a potent inhibitor of AHL-dependent QS pathways, acting on key molecular targets such as AHL synthases, receptor proteins, and downstream virulence regulators. − In the case of FAB NPs, the simultaneous presence of silver and baicalein may result in additive or synergistic interference with QS signaling, contributing to the stronger suppression of violacein biosynthesis observed in C. violaceum (Figure A). A similar but more moderate trend was observed in both S. aureus QS reporter strains (P2 and P3), where FA and FAB NPs induced a statistically significant yet modest reduction in GFP expression compared to Fe3O4 NPs, suggesting that the presence of silver, and possibly partial Ag+ release, is required to induce QS inhibition in Gram-positive bacteria (Figure B). Notably, the comparable responses induced by FA and FAB NPs in both agr P2 and P3 reporters indicate that baicalein likely plays only a secondary role in the modulation of Gram-positive QS pathways, consistent with previous reports showing that silver-containing materials downregulate QS-associated genes in staphylococci. The attenuated QSI response observed in S. aureus, relative to Gram-negative models, may reflect fundamental differences in cell envelope architecture, as Gram-positive bacteria possess a substantially thicker peptidoglycan layer enriched with teichoic acids that can limit NPs interaction and Ag+ penetration, thereby reducing the impact on intracellular signaling processes such as QS regulation. Therefore, the differences observed in biofilm inhibition among Fe3O4, FA and FAB NPs treatments (Figure ) result from a combined disruption of QS signaling (Figure ) and alterations in bacterial population density (Figure ).
To further investigate the mechanisms underlying biofilm and antimicrobial activity, SEM analyses were conducted on bacteria after exposure to FAB NPs, as this novel formulation displayed significant antimicrobial and antibiofilm activity, along with marked inhibition of QS, and lower Ag+ release. SEM observations revealed significant bacterial morphological alterations and NP-cell interactions, providing visual evidence that supports the observed microbial and biofilm suppression (Figure ).
9.
SEM image of S. aureus, P. aeruginosa, and E. coli without NPs treatment (control) and treated with FAB NPs at 30,000x (A) and 70,000x (B) magnifications.
Untreated S. aureus, P. aeruginosa, and E. coli displayed their characteristic morphologies, coccal for staphylococci and rod-shaped for bacilli, with smooth surfaces consistent with intact and healthy cells. Following incubation with FAB NPs, all three species exhibited extensive ultrastructural damage, including membrane collapse, surface roughening, pronounced deformation, and reduced cell volume. Gram-negative E. coli and P. aeruginosa additionally showed bleb formation, appearing as small vesicle-like protrusions from the outer membrane, a hallmark of severe cellular stress and a well-recognized defense response to toxic insults and oxidative damage. , Similarly, S. aureus cells displayed marked deformation and structural disruption. These alterations reflect severe cellular stress and are likely to impair bacterial attachment, providing a mechanistic explanation for both the observed antimicrobial activity and biofilm inhibition.
To further probe the underlying mechanism of FAB NPs-membrane interactions suggested by the SEM observations, Langmuir monolayer analyses were performed (Figure S8). FAB NPs alone exhibited a flat isotherm, indicating no inherent surface activity or monolayer formation. However, when inserted into a PEPG monolayer, a lateral expansion of approximately 12 cm2 was observed without significantly altering the collapse pressure relative to pristine PEPG. This right-shift in the π-A isotherm indicates that FAB NPs intercalate into the phospholipid monolayer, disrupting molecular packing while maintaining overall film stability. Such behavior parallels previous reports showing that hybrid or functionalized nanomaterials can intercalate into phospholipid assemblies, disturbing lipid–lipid interactions. The baicalein moieties of FAB NPs, rich in aromatic functionalities, are likely to enhance NP-lipid affinity through hydrophobic insertion and π-π or hydrogen-bonding interactions, thereby promoting monolayer expansion. This displacement effect, observed at biologically relevant lateral pressures (i.e., 30 – 35 mN/m), aligns with a membrane-perturbing mechanism and supports the notion that FAB NPs may exert part of their antimicrobial action through modulation of lipid packing and increased membrane disorder. Collectively, these findings corroborate the SEM data, demonstrating that FAB NP-induced alterations in membrane integrity can interfere with the early attachment phase of biofilm formation. − The convergence of antimicrobial activity, FAB-mediated QS suppression, and membrane disruption provides a coherent mechanistic basis for the observed reduction in biofilm formation across bacterial species. By impairing cell morphology and compromising membrane integrity, FAB NPs consequently interfere with early attachment, hindering the transition from planktonic to sessile lifestyles. This combined effect, effectively suppressing biofilm development and bacterial aggregation on surfaces, may contribute to the mitigation of AMR. ,,
3.4. Cytotoxicity Assessment in Mammalian Cells
As demonstrated in previous sections, both FA and FAB NPs exhibit pronounced antimicrobial and biofilm inhibition activity, highlighting their potential applications in bacterial disinfection and infection control. For silver-based nanomaterials to be considered for biomedical use, it is essential to balance antimicrobial efficacy with adequate biocompatibility toward mammalian cells. Therefore, the cytotoxicity of Fe3O4, FA, and FAB NPs was evaluated after 24 h of incubation using human fibroblasts and keratinocytes (Figure ). Fe3O4 NPs showed consistent cell viability across all the concentrations tested proving high biocompatibility. This observation agrees with their well-documented use in biomedical applications, including drug delivery, magnetic resonance imaging, and hyperthermia, where biocompatibility is a critical requirement. By contrast, FA NPs displayed high cytotoxicity in both model cells even at 0.05 mg/mL. Notably, FAB NPs maintained more than 80% cell viability up to 0.75 mg/mL, indicating that baicalein capping effectively mitigates cytotoxic effects. This improved biocompatibility can be attributed to the substantially reduced Ag+ release observed for FAB NPs (Figure ), as lower metal ion exposure is generally associated with decreased cytotoxicity in mammalian systems. In addition to limiting Ag+ release, FAB NPs were shown to exhibit intrinsic antioxidant properties (Figure ), which further contribute to their favorable profile. This multifunctional behavior is particularly relevant, as oxidative stress is a key contributor to the cytotoxicity commonly associated with silver-based nanomaterials. The antioxidant capacity of FAB NPs may therefore play a complementary role in mitigating Ag-induced cellular damage, acting alongside the reduced Ag+ release to preserve mammalian cell viability.
10.
In vitro cytotoxicity of Fe3O4, FA, and FAB NPs at various concentrations following 24 h incubation with human fibroblasts (A) and keratinocytes (B). “C” on the x-axis denotes the control group.
Consistently, the reduced toxicity of FAB NPs was further supported by the absence of detectable alterations in cell morphology, which was comparable to that observed for silver-free Fe3O4 NPs (Figure ). By effectively decoupling antibacterial efficacy from cytotoxic effects, baicalein functionalization emerges as a promising strategy to engineer safer silver-based nanomaterials. Overall, the combination of antimicrobial, antioxidant, biocompatible, and magnetic properties position FAB NPs as attractive candidates for biomedical applications, including magnetic-assisted antimicrobial coatings, wound-related materials, and other therapeutics where bacterial control and host cell viability are crucial.
11.
Representative fluorescence microscopy images of human keratinocytes (A-D) and fibroblasts (E-H) following 24 h incubation with Fe3O4, FA, FAB NPs, or without NPs (controls; D and H). Cells were stained using calcein-AM and ethidium homodimer-1 to visualize live (green) and dead (red) cells, respectively.
3.5. Resistance Development
Given the multiple antibacterial mechanisms exhibited by FAB NPs, we hypothesized that they may prevent the emergence of bacterial resistance. AMR is a naturally occurring process in which bacteria develop the ability to withstand the effects of a specific antimicrobial agent after prolonged exposure. Conventional antibiotics typically target specific cellular processes or molecules essential for bacterial survival. When exposed to an antibiotic, susceptible bacteria are inhibited or eliminated, while those harboring resistance traits persist. , The World Health Organization (WHO) has identified AMR as a major global health threat requiring immediate attention.
To evaluate resistance development, S. aureus and E. coli were selected as representative Gram-positive and Gram-negative model organisms, respectively. Both strains were continuously exposed for 55 days to either FAB NPs or conventional antibiotics to which they are known to be susceptible, i.e., ciprofloxacin for S. aureus and ampicillin for E. coli. Following prolonged antibiotic exposure, the MICs increased by 4096- and 256-fold for ciprofloxacin (S. aureus) and ampicillin (E. coli), respectively (Table ), indicating the acquisition of resistance. In contrast, exposure to FAB NPs resulted in only a 2-fold increase in MIC for both bacterial strains, which is minimal and does not indicate significant resistance development.
1. Alterations in MIC for S. aureus and E. coli after 55 Days of Antibiotic or FAB NPs Exposure.
| MIC
Value Change
|
||
|---|---|---|
| Material | S. aureus | E. coli |
| FAB NPs | 2 | 2 |
| Ciprofloxacin | 4096 | - |
| Ampicillin | - | 256 |
Values represent fold changes in MIC relative to Day 1 (e.g., a value of 2 indicates a 2-fold increase in MIC).
Previous studies have explored alternative antibacterial agents, including silver-based and metal oxide NPs. , However, some bacterial strains have been reported to acquire resilience against Ag+ and even Ag NPs. Designing effective antibacterial materials that minimize the emergence of resistant strains remains a major challenge. , FAB NPs, however, exhibit multiple and nonspecific mechanisms of action, such as direct interactions with bacterial surfaces (Figure S7), which likely reduce the probability of resistance development compared to conventional antibiotics. In combination with their demonstrated biocompatibility toward keratinocytes and fibroblasts (Figures and ), these properties position FAB NPs as attractive candidates for the design of novel therapeutic agents, including topical formulations for skin-related infections and antimicrobial coatings for catheters or implantable devices.
3.6. Water Disinfection Efficiency of FAB NPs in Packed Bed Columns
Having demonstrated the multifunctional properties of FAB NPs, including strong antimicrobial and antibiofilm activities, we next explored their potential for environmental applications. Water disinfection remains a significant challenge due to the formation of viable biofilms on conventional filters, such as AC, which can limit disinfection efficiency and potentially contribute to the development of AMR. Therefore, FAB NPs were incorporated into lab-scale packed-bed columns using a neodymium magnetic layer coated with the NPs. Disinfection performance was evaluated using E. coli as the target microorganism, given its widespread use as a reference indicator of faecal contamination and its relevance as a major waterborne pathogen of public health concern. As shown in Figure , complete elimination of E. coli from artificially contaminated water was achieved after 8 h of sample recirculation. As expected, AC control columns demonstrated poor performance in E. coli removal, achieving less than a 1-log reduction in bacterial count in the filtered samples after 18 h of recirculation. This limited removal was mainly attributed to bacterial adsorption onto the filter media rather than to an active disinfection mechanism. Additionally, the use of FAB NPs as a filler in AC columns for water disinfection proved to be environmentally safe, as the concentration of Ag+ detected in the treated effluent remained below the detection limit of the ICP-MS method (LOD < 0.25 μg/L). This finding mitigates concerns regarding the potential environmental impact associated with the release of toxic silver species from FAB NPs into treated water. These results are consistent with the enhanced stability observed for baicalein-functionalized NPs, as shown in Figure . Furthermore, the WHO has established a guideline value for Ag+ in drinking water of 100 μg/L, based on potential aesthetic effects on water physical properties, as no significant health risks have been identified at Ag+ concentrations below this threshold.
12.

E. coli removal from contaminated water in lab-scale packed-bed columns filled with activated carbon (AC) or AC mixed with FAB NPs during 18 h of recirculation.
It is also worth noting that the bacterial load used to feed the columns in this study (∼107 CFU/mL) was significantly higher than the microbial concentrations typically detected in real secondary effluents, which generally range from 103 to 106 CFU per 100 mL. Therefore, under more realistic operational conditions, it is expected that a filtration system incorporating FAB NPs would exhibit even higher disinfection efficiency, while reducing treatment time and probably extending column service life. Overall, this work demonstrates that advances in the engineering of nanocomposites integrated into water filtration systems can promote sustainable and effective water treatment solutions with strong potential for real-life applications.
4. Conclusions
In this study, we developed a baicalein-functionalized Fe3O4/Ag nanocomposite (FAB NPs) that integrates antimicrobial efficacy, magnetic responsiveness, antioxidant activity, and enhanced biocompatibility into a single multifunctional platform. The baicalein coating played a key role in stabilizing the nanocomposite, significantly reducing Ag+ release while preserving strong antibacterial, antibiofilm, and quorum sensing (QS) inhibition activities against both Gram-positive and Gram-negative pathogens. Mechanistic investigations demonstrated that FAB NPs interact directly with bacterial membranes, induce severe morphological damage, and disrupt QS pathways, thereby impairing bacterial viability and biofilm formation through multiple, nonspecific mechanisms. This multimodal mode of action translated into a negligible tendency to induce bacterial resistance during prolonged exposure, in contrast to conventional antibiotics. Importantly, baicalein functionalization improved cytocompatibility toward human keratinocytes and fibroblasts, likely due to the combined effects of reduced Ag+ ion release and intrinsic antioxidant activity. Beyond biomedical relevance, the successful integration of FAB NPs into packed-bed filtration columns enabled efficient water disinfection with minimal Ag+ leaching, highlighting their potential for safe and sustainable environmental applications. Overall, this work underscores the potential of biofunctionalized magnetic silver-based nanocomposites as versatile, resistance-mitigating antimicrobial materials, opening new avenues for their implementation in infection control, biomedical devices, and advanced water treatment technologies.
Supplementary Material
Acknowledgments
This work was supported by European Project SYMSITES (HORIZON-101058426). J.B. acknowledges “Becas Chile”-Agencia Nacional de Investigación y Desarrollo (ANID) for providing her with a PhD grant (ID.72220082). G.R. expresses her profound gratitude to Marie Skłodowska-Curie Actions (MSCA) for the invaluable support through providing the Postdoctoral Fellowship Grant (HORIZON-101109383) and SYMSITES (HORIZON-101058426). T.T. is an ICREA Academia professor. We thank the Microscopy and X ray diffraction service (SMiDRX), Universitat Autonoma de Barcelona, and their staff for their support and advice on SEM technique.
The authors confirm that all data supporting the findings of this study are provided within the article.
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.6c02389.
Diffraction parameters, surface pressure–area isotherms, XRD and SAED patterns, HRTEM images, size distribution data, EDX spectrum, XPS spectra, zeta potential, schematic illustrations of activated carbon packed column and synthetic scheme (PDF)
J.B. and G.R.: conceptualization, methodology, formal analysis, investigation, visualization, writing original draft preparation. A.P.S., K.I., and A.I.: methodology, formal analysis, investigation, visualization. L.M.P.: formal analysis, validation, visualization, supervision, writing, reviewing, and editing. T.T.: supervision, project administration, funding acquisition, resources, writing, reviewing, and editing.
The authors declare no competing financial interest.
References
- Li P., Yin R., Cheng J., Lin J.. Bacterial Biofilm Formation on Biomaterials and Approaches to Its Treatment and Prevention. International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute (MDPI) 2023;24:11680. doi: 10.3390/ijms241411680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nunez C., Kostoulias X., Peleg A., Short F., Qu Y.. A Comprehensive Comparison of Biofilm Formation and Capsule Production for Bacterial Survival on Hospital Surfaces. Biofilm. 2023;5:100105. doi: 10.1016/j.bioflm.2023.100105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rather M. A., Gupta K., Mandal M.. Microbial Biofilm: Formation, Architecture, Antibiotic Resistance, and Control Strategies. Brazilian Journal of Microbiology. 2021;52:1701–1718. doi: 10.1007/s42770-021-00624-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akram, F. ; Imtiaz, M. ; Haq, I. ul . Emergent Crisis of Antibiotic Resistance: A Silent Pandemic Threat to 21st Century. Microbial Pathogenesis; Academic Press, 2023; 10.1016/j.micpath.2022.105923. [DOI] [PubMed] [Google Scholar]
- Bowler, P. ; Murphy, C. ; Wolcott, R. . Biofilm Exacerbates Antibiotic Resistance: Is This a Current Oversight in Antimicrobial Stewardship? Antimicrobial Resistance and Infection Control 2020. 9 10.1186/s13756-020-00830-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nahum, Y. ; Muhvich, J. ; Morones-Ramirez, J. R. ; Casillas-Vega, N. G. ; Zaman, M. H. . Biofilms as Potential Reservoirs of Antimicrobial Resistance in Vulnerable Settings. Front. Public Health 2025, 13. 10.3389/fpubh.2025.1568463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang, Y. ; Guo, X. ; Wu, Y. ; Chen, X. ; Feng, L. ; Xie, N. ; Shen, G. . Nanotechnology’s Frontier in Combatting Infectious and Inflammatory Diseases: Prevention and Treatment. Signal Transduction and Targeted Therapy; 2024; 10.1038/s41392-024-01745-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodrigues A. S., Batista J. G. S., Rodrigues M. Á. V., Thipe V. C., Minarini L. A. R., Lopes P. S., Lugão A. B.. Advances in Silver Nanoparticles: A Comprehensive Review on Their Potential as Antimicrobial Agents and Their Mechanisms of Action Elucidated by Proteomics. Frontiers in Microbiology Frontiers Media SA. 2024 doi: 10.3389/fmicb.2024.1440065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Das, D. ; Paul, P. . Environmental Impact of Silver Nanoparticles and Its Sustainable Mitigation by Novel Approach of Green Chemistry. Plant Nano Biology; 2025; 10.1016/j.plana.2025.100210. [DOI] [Google Scholar]
- Xu J. K., Zhang F. F., Sun J. J., Sheng J., Wang F., Sun M.. Bio and Nanomaterials Based on Fe3O4. Molecules. MDPI AG. 2014;19:21506–21528. doi: 10.3390/molecules191221506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keshta B. E., Gemeay A. H., Kumar Sinha D., Elsharkawy S., Hassan F., Rai N., Arora C.. State of the Art on the Magnetic Iron Oxide Nanoparticles: Synthesis, Functionalization, and Applications in Wastewater Treatment. Results Chem. 2024;7:101388. doi: 10.1016/j.rechem.2024.101388. [DOI] [Google Scholar]
- Duman, H. ; Eker, F. ; Akdaşçi, E. ; Witkowska, A. M. ; Bechelany, M. ; Karav, S. . Silver Nanoparticles: A Comprehensive Review of Synthesis Methods and Chemical and Physical Properties. Nanomaterials 2024; 10.3390/nano14181527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dutta T., Kim K. H., Deep A., Szulejko J. E., Vellingiri K., Kumar S., Kwon E. E., Yun S. T.. Recovery of Nanomaterials from Battery and Electronic Wastes: A New Paradigm of Environmental Waste Management. Renewable and Sustainable Energy Reviews. 2018;82:3694–3704. doi: 10.1016/j.rser.2017.10.094. [DOI] [Google Scholar]
- Alavi S. E., Alavi S. F., Koohi M., Raza A., Ebrahimi Shahmabadi H.. Nanoparticle-Integrated Metal–Organic Frameworks: A Revolution in next-Generation Drug Delivery Systems. Journal of Pharmaceutical Investigation. 2024:751–783. doi: 10.1007/s40005-024-00691-w. [DOI] [Google Scholar]
- Cardoso, V. F. ; Francesko, A. ; Ribeiro, C. ; Bañobre-López, M. ; Martins, P. ; Lanceros-Mendez, S. . Advances in Magnetic Nanoparticles for Biomedical Applications. Advanced Healthcare Materials; Wiley-VCH Verlag March, 2018; Vol. 7, 10.1002/adhm.201700845. [DOI] [PubMed] [Google Scholar]
- Pieretti, J. C. ; Gonçalves, M. C. ; Nakazato, G. ; Santos de Souza, A. C. ; Boudier, A. ; Seabra, A. B. . Multifunctional Hybrid Nanoplatform Based on Fe3O4@Ag NPs for Nitric Oxide Delivery: Development, Characterization, Therapeutic Efficacy, and Hemocompatibility. J. Mater. Sci. Mater. Med. 2021, 32 (3). 10.1007/s10856-021-06494-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reygaert W. C.. An Overview of the Antimicrobial Resistance Mechanisms of Bacteria. AIMS Microbiol. 2018;4(3):482–501. doi: 10.3934/microbiol.2018.3.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahmed S. K., Hussein S., Qurbani K., Ibrahim R. H., Fareeq A., Mahmood K. A., Mohamed M. G.. Antimicrobial Resistance: Impacts, Challenges, and Future Prospects. Journal of Medicine, Surgery, and Public Health. 2024;2:100081. doi: 10.1016/j.glmedi.2024.100081. [DOI] [Google Scholar]
- Havryliuk O., Rathee G., Blair J., Hovorukha V., Tashyrev O., Morató J., Pérez L. M., Tzanov T.. Unveiling the Potential of CuO and Cu2O Nanoparticles against Novel Copper-Resistant Pseudomonas Strains: An In-Depth Comparison. Nanomaterials. 2024;14(20):1644. doi: 10.3390/nano14201644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slavin Y. N., Ivanova K., Hoyo J., Perelshtein I., Owen G., Haegert A., Lin Y. Y., Lebihan S., Gedanken A., Häfeli U. O., Tzanov T., Bach H.. Novel Lignin-Capped Silver Nanoparticles against Multidrug-Resistant Bacteria. ACS Appl. Mater. Interfaces. 2021;13(19):22098–22109. doi: 10.1021/acsami.0c16921. [DOI] [PubMed] [Google Scholar]
- Ferreres G., Pérez-Rafael S., Palacios Ò., Todorova K., Hinojosa-Caballero D., Torrent-Burgués J., Tzanov T.. Cobalt-Phenolic Nanoparticles-Driven Self-Assembly of Hyaluronic Acid Hydrogels Providing a Multifactorial Approach for Chronic Wound Management. Chemical Engineering Journal. 2024;494:153064. doi: 10.1016/j.cej.2024.153064. [DOI] [Google Scholar]
- Ferreres G., Ivanova K., Torrent-Burgués J., Tzanov T.. Multimodal Silver-Chitosan-Acylase Nanoparticles Inhibit Bacterial Growth and Biofilm Formation by Gram-Negative Pseudomonas Aeruginosa Bacterium. J. Colloid Interface Sci. 2023;646:576–586. doi: 10.1016/j.jcis.2023.04.184. [DOI] [PubMed] [Google Scholar]
- Morena A. G., Bassegoda A., Hoyo J., Tzanov T.. Hybrid Tellurium-Lignin Nanoparticles with Enhanced Antibacterial Properties. ACS Appl. Mater. Interfaces. 2021;13(13):14885–14893. doi: 10.1021/acsami.0c22301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morena A. G., Bassegoda A., Natan M., Jacobi G., Banin E., Tzanov T.. Antibacterial Properties and Mechanisms of Action of Sonoenzymatically Synthesized Lignin-Based Nanoparticles. ACS Appl. Mater. Interfaces. 2022;14(33):37270–37279. doi: 10.1021/acsami.2c05443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ozma, M. A. ; Khodadadi, E. ; Pakdel, F. ; Kamounah, F. S. ; Yousefi, M. ; Yousefi, B. ; Asgharzadeh, M. ; Ganbarov, K. ; Kafil, H. S. . Baicalin, a Natural Antimicrobial and Anti-Biofilm Agent. Journal of Herbal Medicine; 2021; 27 10.1016/j.hermed.2021.100432. [DOI] [Google Scholar]
- Li Y., Zhang C., Liu L., Gong Y., Xie Y., Cao Y.. The Effects of Baicalein or Baicalin on the Colloidal Stability of ZnO Nanoparticles (NPs) and Toxicity of NPs to Caco-2 Cells. Toxicol. Mech. Methods. 2018;28(3):167–176. doi: 10.1080/15376516.2017.1376023. [DOI] [PubMed] [Google Scholar]
- Rajkumari J., Busi S., Vasu A. C., Reddy P.. Facile Green Synthesis of Baicalein Fabricated Gold Nanoparticles and Their Antibiofilm Activity against Pseudomonas aeruginosa PAO1. Microb. Pathog. 2017;107:261–269. doi: 10.1016/j.micpath.2017.03.044. [DOI] [PubMed] [Google Scholar]
- Wang, Y. ; Su, J. ; Zhou, Z. ; Yang, J. ; Liu, W. ; Zhang, Y. ; Zhang, P. ; Guo, T. ; Li, G. . Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline. Microbiol. Spectr. 2023, 11 (3). 10.1128/spectrum.04702-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ivanova K., Ivanova A., Hoyo J., Pérez-Rafael S., Tzanov T.. Nano-Formulation Endows Quorum Quenching Enzyme-Antibiotic Hybrids with Improved Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa . Int. J. Mol. Sci. 2022;23(14):7632. doi: 10.3390/ijms23147632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- James E. H., Edwards A. M., Wigneshweraraj S.. Transcriptional Downregulation of Agr Expression in Staphylococcus aureus during Growth in Human Serum Can Be Overcome by Constitutively Active Mutant Forms of the Sensor Kinase AgrC. FEMS Microbiology Letters. 2013;349:153–162. doi: 10.1111/1574-6968.12309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morohoshi T., Kato M., Fukamachi K., Kato N., Ikeda T.. N-Acylhomoserine Lactone Regulates Violacein Production in Chromobacterium violaceum Type Strain ATCC 12472. FEMS Microbiol. Lett. 2008;279(1):124–130. doi: 10.1111/j.1574-6968.2007.01016.x. [DOI] [PubMed] [Google Scholar]
- Ivanova, A. ; Ivanova, K. ; Tied, A. ; Heinze, T. ; Tzanov, T. . Layer-By-Layer Coating of Aminocellulose and Quorum Quenching Acylase on Silver Nanoparticles Synergistically Eradicate Bacteria and Their Biofilms. Adv. Funct. Mater. 2020, 30 (24). 10.1002/adfm.202001284. [DOI] [Google Scholar]
- Performance Standards for Antimicrobial Susceptibility Testing, 27th ed.; CLSI. M100Wayne: Clinical and Laboratory Standards Institute, 2017. [Google Scholar]
- Blair J., Rathee G., Puertas-Segura A., Pérez L. M., Tzanov T.. Advanced Water Treatment with Antimicrobial Silver-Lignin Nanoparticles Sonochemically-Grafted on Cork Granulates in Activated Carbon Packed-Bed Columns. Environ. Res. 2025;279:121783. doi: 10.1016/j.envres.2025.121783. [DOI] [PubMed] [Google Scholar]
- An G. S.. Synthesis of Silver-Decorated Magnetite Nanoparticles Using Self-Assembly Methods. Processes. 2024;12(6):1133. doi: 10.3390/pr12061133. [DOI] [Google Scholar]
- Lee S. B., Paek S. M., Oh J. M.. Porous Hybrids Structure between Silver Nanoparticle and Layered Double Hydroxide for Surface-Enhanced Raman Spectroscopy. Nanomaterials. MDPI AG. 2021;11:447. doi: 10.3390/nano11020447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Biesinger M. C., Payne B. P., Grosvenor A. P., Lau L. W. M., Gerson A. R., Smart R. S. C.. Resolving Surface Chemical States in XPS Analysis of First Row Transition Metals, Oxides and Hydroxides: Cr, Mn, Fe, Co and Ni. Appl. Surf. Sci. 2011;257(7):2717–2730. doi: 10.1016/j.apsusc.2010.10.051. [DOI] [Google Scholar]
- Lesiak, B. ; Rangam, N. ; Jiricek, P. ; Gordeev, I. ; Tóth, J. ; Kövér, L. ; Mohai, M. ; Borowicz, P. . Surface Study of Fe3O4 Nanoparticles Functionalized With Biocompatible Adsorbed Molecules. Front. Chem. 2019, 7. 10.3389/fchem.2019.00642. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rocha T. C. R., Oestereich A., Demidov D. V., Hävecker M., Zafeiratos S., Weinberg G., Bukhtiyarov V. I., Knop-Gericke A., Schlögl R.. The Silver-Oxygen System in Catalysis: New Insights by near Ambient Pressure X-Ray Photoelectron Spectroscopy. Phys. Chem. Chem. Phys. 2012;14:4554–4564. doi: 10.1039/c2cp22472k. [DOI] [PubMed] [Google Scholar]
- Guo M., Dongfang N., Iannuzzi M., van Bokhoven J. A., Artiglia L.. Structure and Reactivity of Active Oxygen Species on Silver Surfaces for Ethylene Epoxidation. ACS Catal. 2024;14(13):10234–10244. doi: 10.1021/acscatal.4c01566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goya G. F., Berquó T. S., Fonseca F. C., Morales M. P.. Static and Dynamic Magnetic Properties of Spherical Magnetite Nanoparticles. J. Appl. Phys. 2003;94(5):3520–3528. doi: 10.1063/1.1599959. [DOI] [Google Scholar]
- Kavithaa K., Paulpandi M., Padma P. R., Sumathi S.. Induction of Intrinsic Apoptotic Pathway and Cell Cycle Arrest: Via Baicalein Loaded Iron Oxide Nanoparticles as a Competent Nano-Mediated System for Triple Negative Breast Cancer Therapy. RSC Adv. 2016;6(69):64531–64543. doi: 10.1039/C6RA11658B. [DOI] [Google Scholar]
- Gabrielyan L., Hovhannisyan A., Gevorgyan V., Ananyan M., Trchounian A.. Antibacterial Effects of Iron Oxide (Fe3O4) Nanoparticles: Distinguishing Concentration-Dependent Effects with Different Bacterial Cells Growth and Membrane-Associated Mechanisms. Appl. Microbiol. Biotechnol. 2019;103(6):2773–2782. doi: 10.1007/s00253-019-09653-x. [DOI] [PubMed] [Google Scholar]
- Sharaf, E. M. ; Hassan, A. ; AL-Salmi, F. A. ; Albalwe, F. M. ; Albalawi, H. M. R. ; Darwish, D. B. ; Fayad, E. . Synergistic Antibacterial Activity of Compact Silver/Magnetite Core-Shell Nanoparticles Core Shell against Gram-Negative Foodborne Pathogens. Front. Microbiol. 2022, 13. 10.3389/fmicb.2022.929491. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang R., Liang B., Han D., Guo Z., Yang C., Yang J., Qiu Y., Li Q., Guo S., Shi J., Zhou X., Qiang T., Guo T.. Synthesis and Antibacterial Activity of Magnetic Fe3O4-Loaded Silver Nanocomposites. J. Alloys Compd. 2024;973:172849. doi: 10.1016/j.jallcom.2023.172849. [DOI] [Google Scholar]
- Mu, L. ; Xie, K. ; Chen, R. ; Cao, J. ; Shu, Y. ; Huang, X. . The Antibacterial Activity, Action Mechanisms and Prospects of Baicalein as an Antibacterial Adjuvant. World J. Microbiol. Biotechnol.; Springer Science and Business Media B.V., 2025; 10.1007/s11274-025-04508-2. [DOI] [PubMed] [Google Scholar]
- Liu, D. ; Lu, Y. ; Li, Z. ; Pang, X. ; Gao, X. . Quorum Sensing: Not Just a Bridge Between Bacteria. MicrobiologyOpen; John Wiley and Sons Inc, 2025; 10.1002/mbo3.70016 March 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qais F. A., Ahmad I., Altaf M., Manoharadas S., Al-Rayes B. F., Ali Abuhasil M. S., Almaroai Y. A.. Biofabricated Silver Nanoparticles Exhibit Broad-Spectrum Antibiofilm and Antiquorum Sensing Activity against Gram-Negative Bacteria. RSC Adv. 2021;11(23):13700–13710. doi: 10.1039/D1RA00488C. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gómez-Gómez B., Arregui L., Serrano S., Santos A., Pérez-Corona T., Madrid Y.. Unravelling Mechanisms of Bacterial Quorum Sensing Disruption by Metal-Based Nanoparticles. Sci. Total Environ. 2019;696:133869. doi: 10.1016/j.scitotenv.2019.133869. [DOI] [PubMed] [Google Scholar]
- Ali, S. G. ; Ansari, M. A. ; Sajid Jamal, Q. M. ; Khan, H. M. ; Jalal, M. ; Ahmad, H. ; Mahdi, A. A. . Antiquorum Sensing Activity of Silver Nanoparticles in P. aeruginosa: An in Silico Study. In Silico Pharmacol. 2017, 5 (1). 10.1007/s40203-017-0031-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luo J., Kong J. L., Dong B. Y., Huang H., Wang K., Wu L. H., Hou C. C., Liang Y., Li B., Chen Y. Q.. Baicalein Attenuates the Quorum Sensing-Controlled Virulence Factors of Pseudomonas aeruginosa and Relieves the Inflammatory Response in P. aeruginosa-Infected Macrophages by Downregulating the MAPK and NFκB Signal-Transduction Pathways. Drug Des. Devel. Ther. 2016;10:183–203. doi: 10.2147/DDDT.S97221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luo J., Dong B., Wang K., Cai S., Liu T., Cheng X., Lei D., Chen Y., Li Y., Kong J., Chen Y.. Baicalin Inhibits Biofilm Formation, Attenuates the Quorum Sensing-Controlled Virulence and Enhances Pseudomonas aeruginosa Clearance in a Mouse Peritoneal Implant Infection Model. PLoS One. 2017;12(4):e0176883. doi: 10.1371/journal.pone.0176883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zong B., Xiao Y., Wang P., Liu W., Ren M., Li C., Fu S., Zhang Y., Qiu Y.. Baicalin Weakens the Virulence of Porcine Extraintestinal Pathogenic Escherichia Coli by Inhibiting the LuxS/AI-2 Quorum-Sensing System. Biomolecules. 2024;14(4):452. doi: 10.3390/biom14040452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang, J. ; Li, J. ; Guo, G. ; Wang, Q. ; Tang, J. ; Zhao, Y. ; Qin, H. ; Wahafu, T. ; Shen, H. ; Liu, X. ; Zhang, X. . Silver-Nanoparticles-Modified Biomaterial Surface Resistant to Staphylococcus: New Insight into the Antimicrobial Action of Silver. Sci. Rep. 2016, 6. 10.1038/srep32699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alabresm A., Chandler S. L., Benicewicz B. C., Decho A. W.. Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape. Bioconjugate Chemistry. 2021;32:1411–1430. doi: 10.1021/acs.bioconjchem.1c00116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mozaheb N., Mingeot-Leclercq M. P.. Membrane Vesicle Production as a Bacterial Defense Against Stress. Frontiers in Microbiology.Frontiers Media S.A. 2020 doi: 10.3389/fmicb.2020.600221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hosnedlova B., Kabanov D., Kepinska M., B Narayanan V. H., Parikesit A. A., Fernandez C., Bjørklund G., Nguyen H. V., Farid A., Sochor J., Pholosi A., Baron M., Jakubek M., Kizek R.. Effect of Biosynthesized Silver Nanoparticles on Bacterial Biofilm Changes in S. aureus and E. coli . Nanomaterials. 2022;12(13):2183. doi: 10.3390/nano12132183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manoharadas S., Altaf M., Alrefaei A. F., Devasia R. M., Badjah Hadj A. Y. M., Abuhasil M. S. A.. Concerted Dispersion of Staphylococcus Aureus Biofilm by Bacteriophage and “green Synthesized” Silver Nanoparticles. RSC Adv. 2021;11(3):1420–1429. doi: 10.1039/D0RA09725J. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Muhammad M. H., Idris A. L., Fan X., Guo Y., Yu Y., Jin X., Qiu J., Guan X., Huang T.. Beyond Risk: Bacterial Biofilms and Their Regulating Approaches. Frontiers in Microbiology. Frontiers Media S.A. 2020 doi: 10.3389/fmicb.2020.00928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruhal, R. ; Kataria, R. . Biofilm Patterns in Gram-Positive and Gram-Negative Bacteria. Microbiological Research; Elsevier GmbH, 2021; 10.1016/j.micres.2021.126829. [DOI] [PubMed] [Google Scholar]
- Sauer K., Stoodley P., Goeres D. M., Hall-Stoodley L., Burmølle M., Stewart P. S., Bjarnsholt T.. The Biofilm Life Cycle: Expanding the Conceptual Model of Biofilm Formation. Nature Reviews Microbiology. Nature Research. 2022;20:608–620. doi: 10.1038/s41579-022-00767-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu, Y. ; Shi, L. ; Su, L. ; Van der Mei, H. C. ; Jutte, P. C. ; Ren, Y. ; Busscher, H. J. . Nanotechnology-Based Antimicrobials and Delivery Systems for Biofilm-Infection Control. Chemical Society Reviews; Royal Society of Chemistry, 2019; pp 428–446. 10.1039/c7cs00807d. [DOI] [PubMed] [Google Scholar]
- Akter M., Sikder M. T., Rahman M. M., Ullah A. K.M. A., Hossain K. F. B., Banik S., Hosokawa T., Saito T., Kurasaki M.. A Systematic Review on Silver Nanoparticles-Induced Cytotoxicity: Physicochemical Properties and Perspectives. Journal of Advanced Research. 2018:1–16. doi: 10.1016/j.jare.2017.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghazi R., Ibrahim T. K., Nasir J. A., Gai S., Ali G., Boukhris I., Rehman Z.. Iron Oxide Based Magnetic Nanoparticles for Hyperthermia, MRI and Drug Delivery Applications: A Review. RSC Advances. 2025:11587–11616. doi: 10.1039/d5ra00728c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Das B., Tripathy S., Adhikary J., Chattopadhyay S., Mandal D., Dash S. K., Das S., Dey A., Dey S. K., Das D., Roy S.. Surface Modification Minimizes the Toxicity of Silver Nanoparticles: An in Vitro and in Vivo Study. Journal of Biological Inorganic Chemistry. 2017;22(6):893–918. doi: 10.1007/s00775-017-1468-x. [DOI] [PubMed] [Google Scholar]
- WHO. Antimicrobial Resistance Global Report on Surveillance, 2014. https://www.who.int/publications/i/item/9789241564748(accessed 2026-01-13).
- Ching, C. ; Zaman, M. H. . Development and Selection of Low-Level Multi-Drug Resistance over an Extended Range of Sub-Inhibitory Ciprofloxacin Concentrations in Escherichia coli . Sci. Rep. 2020, 10 (1). 10.1038/s41598-020-65602-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Monika, P. ; Krishna, R. H. ; Baliga, A. B. ; Ravisagar, K. ; Roy, R. S. ; Lalitha, K. C. ; Kumar, S. G. . Unveiling New Frontiers in Advancements of Metal Oxides Nanoparticles (ZnO, TiO2, CuO and Ag2O) and Their Hybrids for Antibacterial Applications: A Review on Mechanistic Insights and Toxicity. Hybrid Advances; Elsevier B.V, 2025; 10.1016/j.hybadv.2025.100522. [DOI] [Google Scholar]
- Hochvaldová, L. ; Panáček, D. ; Válková, L. ; Večeřová, R. ; Kolář, M. ; Prucek, R. ; Kvítek, L. ; Panáček, A. . E. coli and S. aureus Resist Silver Nanoparticles via an Identical Mechanism, but through Different Pathways. Commun. Biol. 2024, 7 (1). 10.1038/s42003-024-07266-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McNeilly O., Mann R., Hamidian M., Gunawan C.. Emerging Concern for Silver Nanoparticle Resistance in Acinetobacter Baumannii and Other Bacteria. Frontiers in Microbiology. Frontiers Media S.A. 2021 doi: 10.3389/fmicb.2021.652863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zahmatkesh, S. ; Bokhari, A. ; Karimian, M. ; Zahra, M. M. A. ; Sillanpää, M. ; Panchal, H. ; Alrubaie, A. J. ; Rezakhani, Y. . A Comprehensive Review of Various Approaches for Treatment of Tertiary Wastewater with Emerging Contaminants: What Do We Know? Environmental Monitoring and Assessment; Springer Science and Business Media Deutschland GmbH, 2022; 10.1007/s10661-022-10503-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WHO. Guidelines for Drinking-Water Quality. 2017. https://www.who.int/publications/i/item/9789241549950 (accessed 2026-01-13).
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The authors confirm that all data supporting the findings of this study are provided within the article.








